176 related articles for article (PubMed ID: 17697703)
21. Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis.
Chung WH; Hung SI
J Dermatol Sci; 2012 Jun; 66(3):190-6. PubMed ID: 22541332
[TBL] [Abstract][Full Text] [Related]
22. Association between HLA and Stevens-Johnson syndrome induced by carbamazepine in Southern Han Chinese: genetic markers besides B*1502?
Shi YW; Min FL; Qin B; Zou X; Liu XR; Gao MM; Wang Q; Zhou JQ; Liao WP
Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):58-64. PubMed ID: 22348435
[TBL] [Abstract][Full Text] [Related]
23. Association between the HLA-B alleles and carbamazepine-induced SJS/TEN: A meta-analysis.
Wang Q; Sun S; Xie M; Zhao K; Li X; Zhao Z
Epilepsy Res; 2017 Sep; 135():19-28. PubMed ID: 28618376
[TBL] [Abstract][Full Text] [Related]
24. Human leukocyte antigens and drug hypersensitivity.
Chung WH; Hung SI; Chen YT
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
[TBL] [Abstract][Full Text] [Related]
25. Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions.
Amstutz U; Shear NH; Rieder MJ; Hwang S; Fung V; Nakamura H; Connolly MB; Ito S; Carleton BC;
Epilepsia; 2014 Apr; 55(4):496-506. PubMed ID: 24597466
[TBL] [Abstract][Full Text] [Related]
26. Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland.
Wang Q; Zhou JQ; Zhou LM; Chen ZY; Fang ZY; Chen SD; Yang LB; Cai XD; Dai QL; Hong H; Wang HX
Seizure; 2011 Jul; 20(6):446-8. PubMed ID: 21397523
[TBL] [Abstract][Full Text] [Related]
27. HLA-A*31: 01 and HLA-B*15:02 association with Stevens-Johnson syndrome and toxic epidermal necrolysis to carbamazepine in a multiethnic Malaysian population.
Khor AH; Lim KS; Tan CT; Kwan Z; Tan WC; Wu DB; Ng CC
Pharmacogenet Genomics; 2017 Jul; 27(7):275-278. PubMed ID: 28570299
[TBL] [Abstract][Full Text] [Related]
28. Carbamazepine Induces Focused T Cell Responses in Resolved Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Cases But Does Not Perturb the Immunopeptidome for T Cell Recognition.
Mifsud NA; Illing PT; Lai JW; Fettke H; Hensen L; Huang Z; Rossjohn J; Vivian JP; Kwan P; Purcell AW
Front Immunol; 2021; 12():653710. PubMed ID: 33912179
[TBL] [Abstract][Full Text] [Related]
29. HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis.
Genin E; Chen DP; Hung SI; Sekula P; Schumacher M; Chang PY; Tsai SH; Wu TL; Bellón T; Tamouza R; Fortier C; Toubert A; Charron D; Hovnanian A; Wolkenstein P; Chung WH; Mockenhaupt M; Roujeau JC
Pharmacogenomics J; 2014 Jun; 14(3):281-8. PubMed ID: 24322785
[TBL] [Abstract][Full Text] [Related]
30. The HLA-B*15:02 allele in a Spanish Romani patient with carbamazepine-induced Stevens-Johnson syndrome.
Bellón T; Ramírez E; Borobia AM; Lerma V; Moreno-Hidalgo MA; Laosa O; Aramburu JA; González-Herrada C; de Abajo FJ
Pharmacogenomics; 2016 Apr; 17(6):541-5. PubMed ID: 27020614
[TBL] [Abstract][Full Text] [Related]
31. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
[TBL] [Abstract][Full Text] [Related]
32. HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
Kim SH; Kim M; Lee KW; Kim SH; Kang HR; Park HW; Jee YK
Pharmacogenomics; 2010 Jun; 11(6):879-84. PubMed ID: 20504258
[TBL] [Abstract][Full Text] [Related]
33. HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population.
Gonçalo M; Coutinho I; Teixeira V; Gameiro AR; Brites MM; Nunes R; Martinho A
Br J Dermatol; 2013 Sep; 169(3):660-5. PubMed ID: 23600531
[TBL] [Abstract][Full Text] [Related]
34. HLA-B∗ 1502 is associated with carbamazepine induced Stevens-Johnson syndrome in North Indian population.
Aggarwal R; Sharma M; Modi M; Garg VK; Salaria M
Hum Immunol; 2014 Nov; 75(11):1120-2. PubMed ID: 25305458
[TBL] [Abstract][Full Text] [Related]
35. A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions.
Lin YT; Chang YC; Hui RC; Yang CH; Ho HC; Hung SI; Chung WH
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):356-64. PubMed ID: 22211830
[TBL] [Abstract][Full Text] [Related]
36. Coupling Genotyping and Computational Modeling in Prediction of Anti-epileptic Drugs that cause Stevens Johnson Syndrome and Toxic Epidermal Necrolysis for Carrier of HLA-B*15:02.
Teh LK; Selvaraj M; Bannur Z; Ismail MI; Rafia H; Law WC; Sapuan S; Puvanarajah S; Ali PS; Salleh MZ
J Pharm Pharm Sci; 2016; 19(1):147-60. PubMed ID: 27096699
[TBL] [Abstract][Full Text] [Related]
37. The HLA-B*15:02 polymorphism and Tegretol
Chouchi M; Kaabachi W; Tizaoui K; Daghfous R; Aidli SE; Hila L
Rev Neurol (Paris); 2018 May; 174(5):278-291. PubMed ID: 29685430
[TBL] [Abstract][Full Text] [Related]
38. Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand.
Tiamkao S; Jitpimolmard J; Sawanyawisuth K; Jitpimolmard S
Int J Clin Pharm; 2013 Aug; 35(4):608-12. PubMed ID: 23649893
[TBL] [Abstract][Full Text] [Related]
39. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
[TBL] [Abstract][Full Text] [Related]
40. Human Leukocyte Antigen Gene Testing and Carbamazepine-Induced Toxic Epidermal Necrolysis: A Study of Pediatric Practice.
Asgarpour JMS; Lam LM; Vogel TK; Goez HR; Fiorillo L
J Cutan Med Surg; 2021; 25(1):25-29. PubMed ID: 32909461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
